Quarterly ResultMay 6, 2026, 04:43 PM
Phibro Q3 Net Sales +10% to $383.5M; Raises FY26 Guidance
AI Summary
Phibro Animal Health Corporation reported strong financial results for its third fiscal quarter ended March 31, 2026, with net sales increasing 10% to $383.5 million and net income rising 15% to $24.0 million. The Animal Health business was a key driver, with sales up 13%. Following this performance, the company updated its financial guidance for fiscal year 2026, raising the lower end of several ranges, and also announced an increase in its revolving credit facility by $125 million and the launch of its Sustainable Solutions Platform.
Key Highlights
- Net sales for Q3 2026 increased 10% to $383.5 million.
- Net income for Q3 2026 rose 15% to $24.0 million.
- Diluted earnings per share for Q3 2026 increased 16% to $0.59.
- Animal Health segment sales grew 13% to $291.2 million in Q3 2026.
- Updated fiscal year 2026 net sales guidance to $1.46 billion to $1.50 billion (14% growth).
- Updated fiscal year 2026 Adjusted EBITDA guidance to $247 million to $255 million (37% growth).
- Increased revolving credit facility by $125 million to an aggregate commitment of $435 million.
- Launched VERRATAIN Verified Sustainability Solutions platform.